North American Pharmaceutical Contract Manufacturing Market Research and Forecast 2018-2023
The major players operating in the pharmaceutical industry consider outsourcing of the product manufacturing to contract manufacturing organizations. The contract manufacturers provide timely and cost-effective services, which in turn, enable the market players to focus on their core competencies. A pharmaceutical contract manufacturer offers comprehensive services to the clients ranging from drug development to the packaging of the products. Some of the services offered by contract manufacturers to their clients can be divided into two main categories: primary manufacturing and secondary manufacturing. The primary manufacturing mainly involves the synthesis of the bulk active pharmaceutical ingredients (API); however, the secondary manufacturing includes the formulation of bulk drug substances into the final drug products such as pills, topical formulations, and types of injectables.
Major factors contributing to the growth of the North American pharmaceutical contract manufacturing market include increasing trend of outsourcing of healthcare services. In addition, patent cliff is another significant factor contributing in the market growth. The ongoing patent expiry of many blockbuster drugs coupled with decreasing profit margins on branded drugs, is forcing most healthcare companies to outsource manufacturing to control costs. Additionally, patent cliffs have cut sales revenue of many branded medications and forced drug makers to consider outsourcing manufacturing to enable control production costs. However, stringent government regulations hinder the market growth. Moreover, rising demand for low cost services and increasing drug discovery is expected to fuel the market growth in the near future.
The North American pharmaceutical contract manufacturing market can be segmented on the basis of category, type, product, and services. On the basis of category, the market is divided as human-based drugs and animals-based drugs. Based on type, the market is segmented into sterile manufacturing and non-sterile manufacturing. Based on the product, the market is bifurcated into OTC drugs, API, finished dosage forms include solid dose, liquid dose and injectable dose, and others such as nutritional products and packaging. Based on the services, the market is sub-divided as manufacturing services, non-clinical services and research and development. Among services, manufacturing segment is expected to be the highest revenue generating segment owing to growing medical device manufacturing.
The North American pharmaceutical contract manufacturing market is further analyzed on the basis of the geographical regions that are contributing significantly towards the growth of the market. The market is analyzed according to the different countries as the US, Canada, Mexico and rest of North America. The US has major share in the North American healthcare and life science market due to the increasing healthcare expenditure that fuels the pharmaceutical contract manufacturing.
Some of the players operating in the North American pharmaceutical contract manufacturing market are AbbVie Inc., Confab Laboratories Inc., Catalent Inc., Allegiant Healthcare Inc., Baxter International Inc., and several others. In order to sustain in the competitive market, these players adopt various strategies such as merger & acquisitions, expansions, joint ventures and product development and partnership and collaboration. For instance, Catalent Inc., in April 2018, announced to invest $5 million in the innovative drug development center of excellence (CoE) at its New Jersey facility. The investment is focused on preclinical to clinical phase 2b formulation, analytical, and manufacturing solutions for orally delivered small molecules.
RESEARCH METHODOLOGY
The market study of pharmaceutical contract manufacturing market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.
Secondary sources include:
Financial reports of companies involved in the market
Authentic Public Databases such as American College of Rheumatology, American Association for Clinical Chemistry (AACC), and American Autoimmune Related Diseases Association (AARDA), among others.
Whitepapers, research-papers, and news blogs
Company websites and their product catalogue
Supplier Websites such as Alibaba, amazon for pricing analysis
The report is intended for drug manufacturers, healthcare provider, government organizations for overall market analysis, and competitive analysis. The report provides in-depth analysis on pricing, market size, intended quality of the product preferred by consumers, initial norms and vehicle segment. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models such as PEST analysis, Porter five analysis delivering insights into the market for better business decisions.
MARKET SEGMENTATION:
North American Pharmaceutical Contract Manufacturing market is segmented on the basis of regional outlook and following segments:
North American Pharmaceutical Contract Manufacturing Market Research and Analysis, By Category
North American Pharmaceutical Contract Manufacturing Market Research and Analysis, By Type
North American Pharmaceutical Contract Manufacturing Market Research and Analysis, By Product
North American Pharmaceutical Contract Manufacturing Market Research and Analysis, By Services
North American Pharmaceutical Contract Manufacturing Market Research and Analysis, By Region
THE REPORT COVERS:
Comprehensive research methodology of North American Pharmaceutical Contract Manufacturing market.
This report also includes detailed and extensive market overview with key analyst insights.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the North American Pharmaceutical Contract Manufacturing market.
Insights about market determinants which are stimulating the North American Pharmaceutical Contract Manufacturing market.
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players
Major factors contributing to the growth of the North American pharmaceutical contract manufacturing market include increasing trend of outsourcing of healthcare services. In addition, patent cliff is another significant factor contributing in the market growth. The ongoing patent expiry of many blockbuster drugs coupled with decreasing profit margins on branded drugs, is forcing most healthcare companies to outsource manufacturing to control costs. Additionally, patent cliffs have cut sales revenue of many branded medications and forced drug makers to consider outsourcing manufacturing to enable control production costs. However, stringent government regulations hinder the market growth. Moreover, rising demand for low cost services and increasing drug discovery is expected to fuel the market growth in the near future.
The North American pharmaceutical contract manufacturing market can be segmented on the basis of category, type, product, and services. On the basis of category, the market is divided as human-based drugs and animals-based drugs. Based on type, the market is segmented into sterile manufacturing and non-sterile manufacturing. Based on the product, the market is bifurcated into OTC drugs, API, finished dosage forms include solid dose, liquid dose and injectable dose, and others such as nutritional products and packaging. Based on the services, the market is sub-divided as manufacturing services, non-clinical services and research and development. Among services, manufacturing segment is expected to be the highest revenue generating segment owing to growing medical device manufacturing.
The North American pharmaceutical contract manufacturing market is further analyzed on the basis of the geographical regions that are contributing significantly towards the growth of the market. The market is analyzed according to the different countries as the US, Canada, Mexico and rest of North America. The US has major share in the North American healthcare and life science market due to the increasing healthcare expenditure that fuels the pharmaceutical contract manufacturing.
Some of the players operating in the North American pharmaceutical contract manufacturing market are AbbVie Inc., Confab Laboratories Inc., Catalent Inc., Allegiant Healthcare Inc., Baxter International Inc., and several others. In order to sustain in the competitive market, these players adopt various strategies such as merger & acquisitions, expansions, joint ventures and product development and partnership and collaboration. For instance, Catalent Inc., in April 2018, announced to invest $5 million in the innovative drug development center of excellence (CoE) at its New Jersey facility. The investment is focused on preclinical to clinical phase 2b formulation, analytical, and manufacturing solutions for orally delivered small molecules.
RESEARCH METHODOLOGY
The market study of pharmaceutical contract manufacturing market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.
Secondary sources include:
Financial reports of companies involved in the market
Authentic Public Databases such as American College of Rheumatology, American Association for Clinical Chemistry (AACC), and American Autoimmune Related Diseases Association (AARDA), among others.
Whitepapers, research-papers, and news blogs
Company websites and their product catalogue
Supplier Websites such as Alibaba, amazon for pricing analysis
The report is intended for drug manufacturers, healthcare provider, government organizations for overall market analysis, and competitive analysis. The report provides in-depth analysis on pricing, market size, intended quality of the product preferred by consumers, initial norms and vehicle segment. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models such as PEST analysis, Porter five analysis delivering insights into the market for better business decisions.
MARKET SEGMENTATION:
North American Pharmaceutical Contract Manufacturing market is segmented on the basis of regional outlook and following segments:
North American Pharmaceutical Contract Manufacturing Market Research and Analysis, By Category
North American Pharmaceutical Contract Manufacturing Market Research and Analysis, By Type
North American Pharmaceutical Contract Manufacturing Market Research and Analysis, By Product
North American Pharmaceutical Contract Manufacturing Market Research and Analysis, By Services
North American Pharmaceutical Contract Manufacturing Market Research and Analysis, By Region
THE REPORT COVERS:
Comprehensive research methodology of North American Pharmaceutical Contract Manufacturing market.
This report also includes detailed and extensive market overview with key analyst insights.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the North American Pharmaceutical Contract Manufacturing market.
Insights about market determinants which are stimulating the North American Pharmaceutical Contract Manufacturing market.
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players
CHAPTER 1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
CHAPTER 2. MARKET OVERVIEW AND INSIGHTS
2.1. MARKET DEFINITION
2.2. VALUE CHAIN OF PHARMACEUTICAL CONTRACT MANUFACTURING MARKET
2.3. ANALYST INSIGHT & CURRENT MARKET TRENDS
2.3.1. KEY FINDINGS
2.3.2. RECOMMENDATION
2.3.3. CONCLUSION
2.4. RULES & REGULATIONS
2.4.1.1. UNITED STATES
2.4.1.2. CANADA
2.4.1.3. OTHERS
CHAPTER 3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. PATENT CLIFFS DRIVING PHARMACEUTICAL CONTRACT MANUFACTURING
3.1.2. INCREASING INVESTMENTS IN RESEARCH AND DEVELOPMENT
3.1.3. GROWING DEMAND FOR INNOVATIVE DRUGS AND MEDICAL DEVICES COUPLED WITH RISING GERIATRIC POPULATION
3.1.4. INORGANIC GROWTH STRATEGIES SUCH AS MERGER & ACQUISITION
3.2. RESTRAINTS
3.2.1. INCREASING LOGISTIC COSTS
3.2.2. STRINGENT GOVERNMENT REGULATIONS
3.2.3. SHIFT TOWARDS APAC REGION DUE TO AVAILABILITY OF LOW COST LABOURS
3.3. OPPORTUNITIES
3.3.1. INCREASING DRUG DISCOVERY AND COMPLEX CLINICAL TRIAL PROTOCOLS FUELS THE PHARMACEUTICAL OUTSOURCING
3.3.2. RISING DEMAND FOR LOW COST SERVICES
CHAPTER 4. MARKET SEGMENTATION
4.1. NORTH AMERICAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY CATEGORY
4.1.1. HUMAN BASED DRUGS
4.1.2. ANIMALS BASED DRUGS
4.2. NORTH AMERICAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY TYPE
4.2.1. STERILE MANUFACTURING
4.2.2. NON-STERILE MANUFACTURING
4.3. NORTH AMERICAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY PRODUCT
4.3.1. OVER-THE-COUNTER (OTC) DRUGS
4.3.2. ACTIVE PHARMACEUTICAL INGREDIENTS (API)
4.3.3. FINISHED DOSAGE FORMULATION (SOLID DOSE, LIQUID DOSE AND INJECTABLE DOSE)
4.3.4. OTHERS (NUTRITIONAL PRODUCTS AND PACKAGING)
4.4. NORTH AMERICAN PHARMACEUTICAL CONTRACT MANUFACTURING BY SERVICES
4.4.1. MANUFACTURING SERVICES
4.4.2. NON-CLINICAL SERVICES SUCH AS SUPPLY CHAIN MANAGEMENT
4.4.3. RESEARCH AND DEVELOPMENT
CHAPTER 5. COMPETITIVE LANDSCAPE
5.1. KEY COMPANY ANALYSIS
5.2. KEY STRATEGY ANALYSIS
CHAPTER 6. REGIONAL ANALYSIS
6.1. NORTH AMERICAN
6.1.1. UNITED STATES
6.1.2. CANADA
6.1.3. MEXICO
6.1.4. REST OF NORTH AMERICA
CHAPTER 7. COMPANY PROFILES
7.1. ABBVIE INC.
7.2. AJINOMOTO ALTHEA, INC.
7.3. ALLEGIANT HEALTHCARE INC.
7.4. ALTRON INC.
7.5. AVARA PHARMACEUTICAL SERVICES, INC.
7.6. BAXTER INTERNATIONAL INC.
7.7. CATALENT, INC.
7.8. CHIP STAR TECHNOLOGY, LLC
7.9. CONFAB LABORATORIES INC.
7.10. DENISON PHARMACEUTICALS, INC.
7.11. DRAVON MEDICAL INC.
7.12. EAST WEST MANUFACTURING, LLC
7.13. GENVION CORPORATION
7.14. HISUN PHARMACEUTICALS USA INC
7.15. HTI PLASTICS, INC.
7.16. LEE BIOSOLUTIONS, INC.
7.17. MCGUFF PHARMACEUTICALS, INC.
7.18. MIKART, INC.
7.19. NEEDLETECH PRODUCTS, INC.
7.20. NEXTPHASE MEDICAL DEVICES, LLC.
7.21. NORTECH SYSTEMS INC.
7.22. PATHEON N.V.
7.23. PFIZER CENTREONE
7.24. PHOENIX DEVENTURES INC.
7.25. PYRAMID LABORATORIES INC.
7.26. ROPACK PHARMA SOLUTIONS
7.27. SANECA PHARMACEUTICALS, A. S.
7.28. SMC LTD.
7.29. STASON PHARMACEUTICALS, INC.
7.30. STERINOVA INC.
7.31. VIBRANT PHARMA INC.
7.32. VITAL LIFE PHARMACEUTICAL INC.
7.33. VIVA PHARMACEUTICAL INC.
7.34. WELLSPRING PHARMACEUTICAL CANADA CORPORATION
7.35. WEST PHARMACEUTICAL SERVICES, INC.
7.36. ZOETIS, INC
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
CHAPTER 2. MARKET OVERVIEW AND INSIGHTS
2.1. MARKET DEFINITION
2.2. VALUE CHAIN OF PHARMACEUTICAL CONTRACT MANUFACTURING MARKET
2.3. ANALYST INSIGHT & CURRENT MARKET TRENDS
2.3.1. KEY FINDINGS
2.3.2. RECOMMENDATION
2.3.3. CONCLUSION
2.4. RULES & REGULATIONS
2.4.1.1. UNITED STATES
2.4.1.2. CANADA
2.4.1.3. OTHERS
CHAPTER 3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. PATENT CLIFFS DRIVING PHARMACEUTICAL CONTRACT MANUFACTURING
3.1.2. INCREASING INVESTMENTS IN RESEARCH AND DEVELOPMENT
3.1.3. GROWING DEMAND FOR INNOVATIVE DRUGS AND MEDICAL DEVICES COUPLED WITH RISING GERIATRIC POPULATION
3.1.4. INORGANIC GROWTH STRATEGIES SUCH AS MERGER & ACQUISITION
3.2. RESTRAINTS
3.2.1. INCREASING LOGISTIC COSTS
3.2.2. STRINGENT GOVERNMENT REGULATIONS
3.2.3. SHIFT TOWARDS APAC REGION DUE TO AVAILABILITY OF LOW COST LABOURS
3.3. OPPORTUNITIES
3.3.1. INCREASING DRUG DISCOVERY AND COMPLEX CLINICAL TRIAL PROTOCOLS FUELS THE PHARMACEUTICAL OUTSOURCING
3.3.2. RISING DEMAND FOR LOW COST SERVICES
CHAPTER 4. MARKET SEGMENTATION
4.1. NORTH AMERICAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY CATEGORY
4.1.1. HUMAN BASED DRUGS
4.1.2. ANIMALS BASED DRUGS
4.2. NORTH AMERICAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY TYPE
4.2.1. STERILE MANUFACTURING
4.2.2. NON-STERILE MANUFACTURING
4.3. NORTH AMERICAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY PRODUCT
4.3.1. OVER-THE-COUNTER (OTC) DRUGS
4.3.2. ACTIVE PHARMACEUTICAL INGREDIENTS (API)
4.3.3. FINISHED DOSAGE FORMULATION (SOLID DOSE, LIQUID DOSE AND INJECTABLE DOSE)
4.3.4. OTHERS (NUTRITIONAL PRODUCTS AND PACKAGING)
4.4. NORTH AMERICAN PHARMACEUTICAL CONTRACT MANUFACTURING BY SERVICES
4.4.1. MANUFACTURING SERVICES
4.4.2. NON-CLINICAL SERVICES SUCH AS SUPPLY CHAIN MANAGEMENT
4.4.3. RESEARCH AND DEVELOPMENT
CHAPTER 5. COMPETITIVE LANDSCAPE
5.1. KEY COMPANY ANALYSIS
5.2. KEY STRATEGY ANALYSIS
CHAPTER 6. REGIONAL ANALYSIS
6.1. NORTH AMERICAN
6.1.1. UNITED STATES
6.1.2. CANADA
6.1.3. MEXICO
6.1.4. REST OF NORTH AMERICA
CHAPTER 7. COMPANY PROFILES
7.1. ABBVIE INC.
7.2. AJINOMOTO ALTHEA, INC.
7.3. ALLEGIANT HEALTHCARE INC.
7.4. ALTRON INC.
7.5. AVARA PHARMACEUTICAL SERVICES, INC.
7.6. BAXTER INTERNATIONAL INC.
7.7. CATALENT, INC.
7.8. CHIP STAR TECHNOLOGY, LLC
7.9. CONFAB LABORATORIES INC.
7.10. DENISON PHARMACEUTICALS, INC.
7.11. DRAVON MEDICAL INC.
7.12. EAST WEST MANUFACTURING, LLC
7.13. GENVION CORPORATION
7.14. HISUN PHARMACEUTICALS USA INC
7.15. HTI PLASTICS, INC.
7.16. LEE BIOSOLUTIONS, INC.
7.17. MCGUFF PHARMACEUTICALS, INC.
7.18. MIKART, INC.
7.19. NEEDLETECH PRODUCTS, INC.
7.20. NEXTPHASE MEDICAL DEVICES, LLC.
7.21. NORTECH SYSTEMS INC.
7.22. PATHEON N.V.
7.23. PFIZER CENTREONE
7.24. PHOENIX DEVENTURES INC.
7.25. PYRAMID LABORATORIES INC.
7.26. ROPACK PHARMA SOLUTIONS
7.27. SANECA PHARMACEUTICALS, A. S.
7.28. SMC LTD.
7.29. STASON PHARMACEUTICALS, INC.
7.30. STERINOVA INC.
7.31. VIBRANT PHARMA INC.
7.32. VITAL LIFE PHARMACEUTICAL INC.
7.33. VIVA PHARMACEUTICAL INC.
7.34. WELLSPRING PHARMACEUTICAL CANADA CORPORATION
7.35. WEST PHARMACEUTICAL SERVICES, INC.
7.36. ZOETIS, INC
LIST OF TABLES
TABLE 1 NORTH AMERICAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE 2 NORTH AMERICAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET RESEARCH AND ANALYSIS BY CATEGORY, 2017-2023 ($ MILLION)
TABLE 3 NORTH AMERICAN HUMAN-BASED DRUGS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 4 NORTH AMERICAN ANIMALS-BASED DRUGS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 5 NORTH AMERICAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
TABLE 6 NORTH AMERICAN STERILE MANUFACTURING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 7 NORTH AMERICAN NON-STERILE MANUFACTURING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 8 NORTH AMERICAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2017-2023 ($ MILLION)
TABLE 9 NORTH AMERICAN OVER-THE COUNTER DRUGS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 10 NORTH AMERICAN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 11 NORTH AMERICAN FINISHED DOSAGE FORMS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 12 NORTH AMERICAN OTHERS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 13 NORTH AMERICAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET RESEARCH AND ANALYSIS BY SERVICES, 2017-2023 ($ MILLION)
TABLE 14 NORTH AMERICAN MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 15 NORTH AMERICAN NON-CLINICAL SERVICES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 16 NORTH AMERICAN RESEARCH AND DEVELOPMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 1 NORTH AMERICAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE 2 NORTH AMERICAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET RESEARCH AND ANALYSIS BY CATEGORY, 2017-2023 ($ MILLION)
TABLE 3 NORTH AMERICAN HUMAN-BASED DRUGS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 4 NORTH AMERICAN ANIMALS-BASED DRUGS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 5 NORTH AMERICAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
TABLE 6 NORTH AMERICAN STERILE MANUFACTURING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 7 NORTH AMERICAN NON-STERILE MANUFACTURING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 8 NORTH AMERICAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2017-2023 ($ MILLION)
TABLE 9 NORTH AMERICAN OVER-THE COUNTER DRUGS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 10 NORTH AMERICAN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 11 NORTH AMERICAN FINISHED DOSAGE FORMS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 12 NORTH AMERICAN OTHERS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 13 NORTH AMERICAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET RESEARCH AND ANALYSIS BY SERVICES, 2017-2023 ($ MILLION)
TABLE 14 NORTH AMERICAN MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 15 NORTH AMERICAN NON-CLINICAL SERVICES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 16 NORTH AMERICAN RESEARCH AND DEVELOPMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
LIST OF FIGURES
FIGURE 1 NORTH AMERICAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE BY CATEGORY, 2017 VS 2023 (%)
FIGURE 2 NORTH AMERICAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE BY TYPE, 2017 VS 2023 (%)
FIGURE 3 NORTH AMERICAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE BY PRODUCT, 2017 VS 2023 (%)
FIGURE 4 NORTH AMERICAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE BY SERVICES, 2017 VS 2023 (%)
FIGURE 5 US PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 6 CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 7 MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 8 REST OF NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2017-2023 ($ MILLION)
COMPANIES MENTIONED
1. ABBVIE INC.
2. AJINOMOTO ALTHEA, INC.
3. ALLEGIANT HEALTHCARE INC.
4. ALTRON INC.
5. AVARA PHARMACEUTICAL SERVICES, INC.
6. BAXTER INTERNATIONAL INC.
7. CATALENT, INC.
8. CHIP STAR TECHNOLOGY, LLC
9. CONFAB LABORATORIES INC.
10. DENISON PHARMACEUTICALS, INC.
11. DRAVON MEDICAL INC.
12. EAST WEST MANUFACTURING, LLC
13. GENVION CORPORATION
14. HISUN PHARMACEUTICALS USA INC
15. HTI PLASTICS, INC.
16. LEE BIOSOLUTIONS, INC.
17. MCGUFF PHARMACEUTICALS, INC.
18. MIKART, INC.
19. NEEDLETECH PRODUCTS, INC.
20. NEXTPHASE MEDICAL DEVICES, LLC.
21. NORTECH SYSTEMS INC.
22. PATHEON N.V.
23. PFIZER CENTREONE
24. PHOENIX DEVENTURES INC.
25. PYRAMID LABORATORIES INC.
26. ROPACK PHARMA SOLUTIONS
27. SANECA PHARMACEUTICALS, A. S.
28. SMC LTD.
29. STASON PHARMACEUTICALS, INC.
30. STERINOVA INC.
31. VIBRANT PHARMA INC.
32. VITAL LIFE PHARMACEUTICAL INC.
33. VIVA PHARMACEUTICAL INC.
34. WELLSPRING PHARMACEUTICAL CANADA CORPORATION
35. WEST PHARMACEUTICAL SERVICES, INC.
36. ZOETIS, INC
FIGURE 1 NORTH AMERICAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE BY CATEGORY, 2017 VS 2023 (%)
FIGURE 2 NORTH AMERICAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE BY TYPE, 2017 VS 2023 (%)
FIGURE 3 NORTH AMERICAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE BY PRODUCT, 2017 VS 2023 (%)
FIGURE 4 NORTH AMERICAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE BY SERVICES, 2017 VS 2023 (%)
FIGURE 5 US PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 6 CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 7 MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 8 REST OF NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2017-2023 ($ MILLION)
COMPANIES MENTIONED
1. ABBVIE INC.
2. AJINOMOTO ALTHEA, INC.
3. ALLEGIANT HEALTHCARE INC.
4. ALTRON INC.
5. AVARA PHARMACEUTICAL SERVICES, INC.
6. BAXTER INTERNATIONAL INC.
7. CATALENT, INC.
8. CHIP STAR TECHNOLOGY, LLC
9. CONFAB LABORATORIES INC.
10. DENISON PHARMACEUTICALS, INC.
11. DRAVON MEDICAL INC.
12. EAST WEST MANUFACTURING, LLC
13. GENVION CORPORATION
14. HISUN PHARMACEUTICALS USA INC
15. HTI PLASTICS, INC.
16. LEE BIOSOLUTIONS, INC.
17. MCGUFF PHARMACEUTICALS, INC.
18. MIKART, INC.
19. NEEDLETECH PRODUCTS, INC.
20. NEXTPHASE MEDICAL DEVICES, LLC.
21. NORTECH SYSTEMS INC.
22. PATHEON N.V.
23. PFIZER CENTREONE
24. PHOENIX DEVENTURES INC.
25. PYRAMID LABORATORIES INC.
26. ROPACK PHARMA SOLUTIONS
27. SANECA PHARMACEUTICALS, A. S.
28. SMC LTD.
29. STASON PHARMACEUTICALS, INC.
30. STERINOVA INC.
31. VIBRANT PHARMA INC.
32. VITAL LIFE PHARMACEUTICAL INC.
33. VIVA PHARMACEUTICAL INC.
34. WELLSPRING PHARMACEUTICAL CANADA CORPORATION
35. WEST PHARMACEUTICAL SERVICES, INC.
36. ZOETIS, INC
